Thrilled to share our new paper in @NatureMedicine! We analyzed 783 patients (2,200+ patient-years) receiving lentiviral or gammaretroviral T cell therapies and found no evidence of high-level insertional mutagenesis. https://t.co/sNGqvjDXMt
Tremendously proud to share my fellowship work, online today in @NatureMedicine. We tried to understand why CAR T therapy for AML doesn't work as well as we hoped it would, and how we can solve that. 👇🧵1/10
@PennMedicine@CHOP_Research@GillSaar https://t.co/Dkp8YsSYJ9
To target high-risk neuroblastoma, which expresses surface GPC2 (tumor-exclusive, but downregulated under immune pressure) and GD2 (not tumor-exclusive) and is infiltrated by CD16a+ innate immune cells [...] https://t.co/srqJwAskXw @CHOP_Research
Congrats to @wolpawlab and thank you to @hopeonwheels for this generous funding towards our research demanding more effective and less toxic therapies for neuroblastoma
Congrats to @ChildrensPhila's Drs. Adam Wolpaw & Timothy Spear who were awarded a combined $650,000 from @hyundaihopeonwheels for #Neuroblastoma research at the nonprofit's handprint ceremony earlier this week. https://t.co/khcuueQblB
@CHOPCancerCntr
Congratulations to this year's class of Conquer Cancer Grant and Award recipients! We can't wait to celebrate with you at #ASCO24! Full list of recipients: https://t.co/mCaRLSVLik
Excited to have our personalized neoantigen vaccine campaign for high-risk neuroblastoma and other pediatric cancers at @CHOPCancerCntr funded by @StBaldricks!
Exciting News! 📢 $1.1M to support young investigators pushing boundaries in pediatric cancer research! Meet the 2024 St. Baldrick’s Fellows and explore their innovative projects in our latest blog post: https://t.co/BfvCQ3LEaJ
Exciting News! 📢 $1.1M to support young investigators pushing boundaries in pediatric cancer research! Meet the 2024 St. Baldrick’s Fellows and explore their innovative projects in our latest blog post: https://t.co/BfvCQ3LEaJ
Grateful to the @AACRFoundation for sponsoring pediatric cancer research at this years Party with a Purpose and helping fund our efforts to develop novel immunotherapies for childhood cancer @CHOPCancerCntr@ChildrensPhila
Party with a Purpose Scientific Achievement Awardee John M. Maris, MD, presented the Party with a Purpose Early-Career Investigator research grant to Timothy Spear, MD, PhD, a pediatric hematology/oncology fellow at @ChildrensPhila.
In conjunction with the Friends of the @AACR Foundation, Party with a Purpose will honor two neuroblastoma researchers from @ChildrensPhila. Learn more on the #AACRBlog: https://t.co/Cq8D7WVEb4